The pharmaceutical landscape is witnessing a development with the arrival of GLP-1 delivery devices. These cutting-edge formulations offer a promising approach to providing glucagon-like peptide-1 drugs for individuals battling type 2 diabetes . Instead of daily shots , a easy-to-use patch affixed to tirzepatide compound the area could administer a